In a significant corporate development, Abbott India Limited has announced the appointment of Ms. Anushree Kunhambu as the Associate Director - New Product Introduction and Therapy Area Strategy. The appointment, which has been approved by the Board of Directors upon the recommendation of the Nomination and Remuneration Committee, is effective August 1, 2025. With this role, Anushree will become a key member of Abbott India's Senior Management Team.

The appointment has been disclosed in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring that the company remains compliant with the regulatory framework for corporate governance and transparency.

Anushree Kunhambu's Profile
Ms. Kunhambu is a seasoned professional with over a decade of experience in the healthcare sector, specializing in business development, licensing, and strategy. She has a proven track record of driving impactful strategic initiatives across prominent organizations in the healthcare space.

Anushree joined Abbott India in April 2021 as the Head of Strategy & Portfolio, EPD India, where she led several high-profile licensing and acquisition deals across key therapy areas, including biosimilars, gastrointestinal, women’s health, and CNS (Central Nervous System). Her leadership in strategy formulation has played a significant role in expanding Abbott India’s product portfolio, driving top-line and bottom-line growth, and enhancing the company’s market competitiveness.

Before joining Abbott, Anushree was instrumental in establishing the Life Sciences vertical for GLG in India, where she worked with numerous pharmaceutical companies and healthcare investment firms. Her contributions to commercial due diligence and research-driven insights have been pivotal in shaping strategic decisions for these organizations.

In her early career, Anushree was a member of the Corporate Strategy team at Cipla, where she executed strategic licensing partnerships across Europe and Rest of World (RoW) markets. She also played a crucial role in evaluating market entry strategies in key international markets such as Turkey and Brazil, focusing on partnerships, B2C models, and inorganic growth.

Anushree holds a BTech in Biotechnology from SRM University and is an alumna of the prestigious Young India Fellowship at Ashoka University, in collaboration with the University of Pennsylvania. Her career journey reflects a strong track record of cross-functional leadership, strategic foresight, and the ability to build and maintain deep industry relationships.

Abbott India continues to enhance its leadership team with individuals who possess the experience and vision necessary to drive the company’s growth in an increasingly competitive healthcare market. Anushree Kunhambu’s appointment is part of this ongoing effort to strengthen its senior management capabilities and maintain its leadership in the industry.

The company has also complied with all the necessary disclosure requirements under SEBI regulations, ensuring that the announcement is made in a timely and transparent manner. Abbott India remains committed to providing its stakeholders with updates about key developments and corporate changes.

In conclusion, Anushree Kunhambu’s appointment marks a significant step in Abbott India’s strategic journey, leveraging her extensive experience and expertise to contribute to the company’s continued success and growth in the Indian pharmaceutical and healthcare sector.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.